Literature DB >> 1759989

Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency.

J Koizumi1, A Inazu, K Yagi, I Koizumi, Y Uno, K Kajinami, S Miyamoto, P Moulin, A R Tall, H Mabuchi.   

Abstract

Six homozygous, 10 heterozygous and 8 unaffected subjects in a CETP deficient family confirmed by CETP gene analysis were studied to characterize serum lipoproteins separated by ultracentrifugation, and to examine the relations between CETP levels and lipoprotein lipid concentration and composition. The serum CETP levels were measured by radioimmunoassay using 125I-labeled monoclonal antibodies (TP2). The serum CETP levels in the homozygotes were undetectable and those in the heterozygotes were significantly lower than those in the unaffected subjects (1.5 +/- 0.1 vs. 2.2 +/- 0.5 microgram/ml, P less than 0.01). In the HDL fraction, esterified cholesterol (EC) levels in the homozygotes were significantly increased (P less than 0.01), and those in the heterozygotes were slightly increased (n.s.), in comparison with those in the unaffected and the normolipidemic controls. The EC levels in the IDL fractions were lower in the homozygotes than in the normolipidemic controls. The EC/triglyceride (TG) molar ratios in IDL, the fraction obtained from the homo- and heterozygotes, were lower than those from the unaffected subjects (P less than 0.01 and less than 0.01, respectively), and the EC/TG ratios in the HDL fraction obtained from the homo- and heterozygotes were higher than those from the unaffected subjects (P less than 0.01 and n.s., respectively). Linear regression analysis showed that positive correlates of the serum CETP levels in all subjects were: IDL-EC (r = 0.463), HDL-TG (r = 0.603) and VLDL- and IDL-EC/TG ratio (r = 0.698 and 0.843).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1759989     DOI: 10.1016/0021-9150(91)90114-i

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  Conformational studies of the N-terminal lipid-associating domain of human apolipoprotein C-I by CD and 1H NMR spectroscopy.

Authors:  A Rozek; G W Buchko; P Kanda; R J Cushley
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

2.  Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile.

Authors:  Lisanne L Blauw; Raymond Noordam; Sebastian Soidinsalo; C Alexander Blauw; Ruifang Li-Gao; Renée de Mutsert; Jimmy F P Berbée; Yanan Wang; Diana van Heemst; Frits R Rosendaal; J Wouter Jukema; Dennis O Mook-Kanamori; Peter Würtz; Ko Willems van Dijk; Patrick C N Rensen
Journal:  Eur J Hum Genet       Date:  2018-11-12       Impact factor: 4.246

Review 3.  Unraveling the complexities of the HDL lipidome.

Authors:  Anatol Kontush; Marie Lhomme; M John Chapman
Journal:  J Lipid Res       Date:  2013-03-30       Impact factor: 5.922

4.  Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

Authors:  A Inazu; X C Jiang; T Haraki; K Yagi; N Kamon; J Koizumi; H Mabuchi; R Takeda; K Takata; Y Moriyama
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

5.  Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia.

Authors:  A Inazu; J Koizumi; T Haraki; K Yagi; T Wakasugi; T Takegoshi; H Mabuchi; R Takeda
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

6.  Cholesteryl ester transfer protein inhibition by PD 140195.

Authors:  C L Bisgaier; A D Essenburg; L L Minton; R Homan; C J Blankley; A White
Journal:  Lipids       Date:  1994-12       Impact factor: 1.880

7.  Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.

Authors:  T Hayek; N Azrolan; R B Verdery; A Walsh; T Chajek-Shaul; L B Agellon; A R Tall; J L Breslow
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; M Nishiwaki; T Sakamoto; T Ishikawa; T Fairwell; L A Zech; M Nagano; H Nakamura; H B Brewer; D J Rader
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 9.  Trials and Tribulations of CETP Inhibitors.

Authors:  Alan R Tall; Daniel J Rader
Journal:  Circ Res       Date:  2017-10-10       Impact factor: 17.367

10.  Metabolic syndrome and its correlated factors in an urban population in South West of Iran.

Authors:  Hajieh Shahbazian; Seyed Mahmoud Latifi; Mohammad Taha Jalali; Heshmatollah Shahbazian; Reza Amani; Abdolrasool Nikhoo; Armaghan Moravej Aleali
Journal:  J Diabetes Metab Disord       Date:  2013-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.